- Anxiety & Depression
- Bipolar Disorder
- Dementia
- Depression
- Epilepsy
- Headache
- Movement Disorder
- Multiple Sclerosis
- Neuropathic Pain
- Psychiatry
- Psychosis
- Stroke
Our Publications
- DSM Dilemma: Issue 5
- DSM Dilemma: Issue 4
- DSM Dilemma: Issue 3
- DSM Dilemma: Issue 2
- DSM Dilemma: Issue 1
- Bright Times: Issue 4
- Mind Matters (Issue 4) - Effective Management of Comorbid Depression and Hypertension: Role of Escitalopram
- Bright Times: Issue 3
- Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes
- Bright Times: Issue 2
- Mind Matters (Issue 2) - Relationship between Depression and Cosmetic Problems: Role of Escitalopram
- Bright Times: Issue 1
- Mind Matters (Issue 1) – Escitalopram: Depression associated with Stroke
- Vilazodone (Vilarest) Monograph
Key Trials
Patient Education
Clinical Tools
Guidelines
- AHA/ASA: Management of Post-stroke Depression (2016)
- ACP: Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients with Major Depressive Disorder: A Clinical Practice Guideline (2016)
- ICSI: Depression, Adult in Primary Care (2016)
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015)
- WFSBP: Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder (2015)
- AACAP: Practice Parameter for the Assessment and Treatment of Children and Adolescents with Obsessive-Compulsive Disorder (2012)
- CANMAT: Recommendations for the Management of Patients With Mood Disorders And Comorbid Anxiety Disorders (2012)
- APA: Major Depressive Disorder: Practice Guidelines (2010)
- APA: Panic Disorder: Practice Guidelines (2009)
- BAP: Evidence-based Guidelines for Treating Depressive Disorders with Antidepressants (2008)
- WFSBP: Consensus Paper on Biological Markers in Depression (2007)
- WFSBP: Treatment Guidelines on Unipolar Depressive Disorder (2007)
- BAP: Evidence-based Guidelines on Pharmacological Treatment of Anxiety, Disorders (2005)
- NICE: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder: Clinical Guidelines (2005)
- NICE: Guidelines for Management of Anxiety (panic disorder, with or without agoraphobia and generalised anxiety disorder) in Adults in Primary Secondary and Community Care (2004)
Our Publications
Key Trials
Clinical Tools
Guidelines
- CANMAT/ISBD: Management of Patients with Bipolar Disorder - An Update (2018)
- BAP: Treatment of Bipolar Disorder (2016)
- BAP: Evidence-based Guidelines for Treating Bipolar Disorder: Revised 3rd Edition (2016)
- CANMAT/ ISBD: Guidelines for the Management of Patients with Bipolar Disorder: An Update (2013)
- CANMAT: Recommendations for the Management of Patients with Mood Disorders And Comorbid Attention-deficit/Hyperactivity Disorder (2012)
- CANMAT: Recommendations for the Management of Patients With Mood Disorders And Comorbid Anxiety Disorders (2012)
- CANMAT: Recommendations for the Management of Patients with Mood Disorders And Comorbid Medical Conditions: Diagnostic Assessment and Treatment Principles (2012)
- CANMAT: Recommendations for the Management of Patients with Mood Disorders And Comorbid Substance Use Disorders (2012)
- AACAP: Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents (2011)
- WFSBP: Guidelines on Biological Treatment of Acute Bipolar Depression: An Update (2010)
- CANMAT/ISBD: Guidelines for the Management of Patients With Bipolar Disorder: An Update (2009)
- AACAP: Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents (2009)
- CANMAT: Guidelines for the Management of Patients with Bipolar Disorder: Consensus and Controversies (2005)
Our Publications
Conference Proceedings
Patient Education
Clinical Tools
Guidelines
- AHA: Impact of Hypertension on Cognitive Function (2016)
- NICE: MID-Life Approaches to Delay or Prevent Onset of Dementia, Disability and Frailty (2015)
- Alzheimer’s Association: Recommendations for Operationalizing the Detection of Cognitive Impairment During the Medicare Annual Wellness Visit in a Primary Care Setting (2013)
- AAN: Evaluation and Management of Driving Risk in Dementia: An Update (2012)
- NIA-Alzheimer’s Association: New Diagnostic Criteria and Guidelines for Alzheimer's Disease (2011)
- WFSBP: Treatment Guidelines on Dementia (2011)
- BAP: Clinical Practice with Anti-Dementia Drugs (2010)
- APA: Alzheimer’s Disease and Other Dementias: Practice Guidelines (2007)
Patient Education
Our Publications
- Mind Matters (Issue 5) – Depression and Epilepsy: The Bidirectional Relationship
- Treatment with Valproate in Females with Epilepsy: Recommendations from ILAE and EAN
- Reduction of Febrile Seizure Recurrence by Oral Levetiracetam
- Epilepsy Times - Issue 8 : Epilepsy and Psychiatric Comorbidity: Emphasis on Lamotrigine
- Epilepsy Times - Issue 7: Prophylactic Anticonvulsants for Post Traumatic Epilepsy (PTE): Role of Levetiracetam
- Epilepsy Times - Issue 6: Newer Anticonvulsants in Patients with Dementia
- Epilepsy Times - Issue 5: Post-stroke Seizures and Post-stroke Epilepsy: Exploring Levetiracetam
- Epilepsy Times - Issue 4: Clinical Tool for Dosage Adjustment of Lamotrigine: Before, During and After Pregnancy
- Epilepsy Times - Issue 3: Levetiracetam Monotherapy in Patients with Brain Tumor Related Epilepsy (BTRE)
- Epilepsy Times - Issue 2: Exposure to Lamotrigine Monotherapy during Pregnancy is Safe: Results from 18 Years of International Lamotrigine Pregnancy Registry
- Levetiracetam in Idiopathic Generalized Epilepsy
- Epilepsy Times - Issue 1: Oxcarbazepine and Epilepsy
- Levetiracetam: Optimal Pharmacological Management of Partial Seizures
Key Trials
- EcLiPSE: Levetiracetam May Be Preferred Over Phenytoin as Second-line Treatment for Pediatric Convulsive Status Epilepticus
- Midazolam Nasal Spray vs. Diazepam Rectal Solution for Treating Seizure Exacerbations in Adults
- NEAD Study: Fetal Exposure to Antiepileptic Medications and Its Impact on IQ and Cognitive Outcomes at Age 6 Years
- SANAD Arm B: Valproate-The First Line Treatment for Generalized as well as Unclassified Seizures
- SANAD Arm A: Efficacy of Newer Antiepileptic Drugs Including Lamotrigine vs. Carbamazepine in Patients with Partial Onset Seizures
Conference Proceedings
Patient Education
Clinical Tools
Guidelines
- AES: New Guideline for Treatment of Prolonged Seizures in Children and Adults (2016)
- AES: Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults (2016)
- AAN: Evidence-based Guideline: Management of an Unprovoked First Seizure in Adults (2015)
- AAN: Vagus Nerve Stimulation for the Treatment of Epilepsy: An Update (2013)
- AAN: Medical Treatment of Infantile Spasms: An Update (2012)
- AAN: Evidence Based Guideline on the Selection of Antiepileptic Drugs for Patients With HIV/AIDS: Summary (2012)
- NICE: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care (2012)
- ILAE: New Concepts in Classification of the Epilepsies: Entering the 21st Century (2011)
- AAN: Practice Guidelines for Management Issue for Women with Epilepsy-Focus on Pregnancy; Teratogenesis and Perinatal Outcomes: An Update (2009)
- AAN: Practice Guidelines for Management Issues for Women with Epilepsy - Focus On Pregnancy; Obstetrical Complications and Change in Seizure Frequency: An Update (2009)
- AAN: Practice Guidelines for Management Issues for Women with Epilepsy - Focus On Pregnancy; Vitamin K, Folic Acid, Blood Levels , and Breastfeeding: An Update (2009)
- ILAE: Revised Terminology and Concepts for Epilepsies (2005–2009)
Our Publications
Conference Proceedings
Patient Education
Guidelines
- AAN/AHS: Acute Treatment of Migraine in Children and Adolescents - An Update (2019)
- AAN/AHS: Pharmacologic Treatment for Pediatric Migraine Prevention (2019)
- AHS: Position Statement on Integrating New Migraine Treatment into Clinical Practice (2019)
- ICSI: Diagnosis and Treatment of Headache (2013)
- International Classification of Headache Disorders (2013)
- IHS: Guideline on Headache Classification (2013)
- AAN & AHS: Guidelines for the Pharmacologic Prevention of Episodic Migraine in Adults: An Update (2012)
- BASH: Guidelines for the Diagnosis and Management of Migraine, Tension-Type headache, Cluster Headache & Medication Overuse Headache (2010)
- EFNS: Guidelines on the Drug Treatment of Migraine: Report (2009)
- SIGNS: Guidelines for the Diagnosis and Management of Headache in Adults (2008)
Patient Education
Guidelines
- AAN: Evaluation, Diagnosis and Management of Facioscapulohumeral Muscular Dystrophy (2015)
- AAN: Evidence Based Guidelines for Tardive Syndromes (2013)
- AAN: Practice Guidelines for the Pharmacological Treatment of Chorea in Huntington Disease (2012)
- AAN: Evidence Based Guidelines for Treatment of Essential Tremors (2011)
- MDS-ES & EFNS: Collaboration Guidelines on Dystonia (2011)
- AAN: Evidence Based Guidelines for Treatment of Nonmotor symptoms of Parkinson's disease (2010)
Key Trials
- Dimethyl Fumarate Associated with better Work Productivity Outcomes Over β Interferon and Glatiramer Acetate Therapies in RRMS Patients
- Dimethyl Fumarate Better than Teriflunomide and as Good as Fingolimod in MS
- Delayed-Release Dimethyl Fumarate Favorably Impacts MRI Parameters in RRMS Patients with Sustained Benefits till 2 Years
- Oral Dimethyl Fumarate-A Potential Initial Treatment for Relapsing-Remitting Multiple Sclerosis
Guidelines
- NICE: Assessment and Management of Low Back Pain and Sciatica in Patients Aged 16 Years and Above (2016)
- AAN/AANEM/AAPM&R: Practice Guidelines on Treatment of Painful Diabetic Neuropathy (2011)
- EFNS: Guidelines on Neuropathic Pain Assessment (2010)
- EFNS: Guidelines on the Pharmacological Treatment of Neuropathic Pain (2010)
- EFNS: Guidelines on Neurostimulation Therapy for Neuropathic Pain (2007)
Guidelines
- AAN: The Utility of EEG Theta/Beta Power Ratio in ADHD Diagnosis (2016)
- ICSI: Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents (2014)
- BAP:Evidence-based Guidelines for the Pharmacological Management of Attention Deficit Hyperactivity Disorder: An Update (2014)
- AACAP: Practice Parameter for the Assessment and Treatment of Children and Adolescents with Autism Spectrum Disorder (2013)
- BAP: Evidence Based Guidelines for the Pharmacological Management of Substance Abuse, Harmful Use, Addiction and Comorbidity: An Update (2012)
- WFSBP: Treatment of Substance Use and Related Disorders; Opioid Dependence (2011)
- NICE: Borderline Personality Disorder Treatment and Management (2009)
- SIGN: Management of ADHD in Children and Young People (2009)
- NICE: Diagnosis and Management of ADHD in Children Young People and Adults (2008)
- WFSBP: Guidelines for Biological Treatment of Personality Disorders (2007)
- APA: Substance Use Disorders: Practice Guidelines (2007)
- APA: Borderline Personality Disorder: Practice Guidelines (2005)
- APA: Suicidal Behaviour: Practice Guidelines (2003)
Our Publications
Key Trials
Patient Education
Clinical Tools
Guidelines
- WFSBP: Acute Treatment of Schizophrenia: (2014)
- NICE: Psychosis and Schizophrenia in Adults: Treatment and Management (2014)
- WFSBP: Long-term Treatment of Schizophrenia and Management of Antipsychotic- Induced Side Effects (2013)
- AACAP: Practice Parameter on the Assessment and Treatment of Children and Adolescents with Schizophrenia (2013)
- WFSBP: Acute Treatment of Schizophrenia and the Management of Treatment Resistance (2012)
- AACAP: Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents (2011)
- BAP: Evidence-based Guidelines for the Pharmacological Treatment of Schizophrenia (2010)
- APA: Practice Guidelines for Schizophrenia (2009)
- AACAP: Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents (2009)
Webcasts
Conference Proceedings
Patient Education
Guidelines
- AHA/ASA: Early Management of Patients with Acute Ischemic Stroke (2018)
- Consensus on Pregnancy, Hormonal Treatment for Infertility, Contraception and Menopause in Women after Ischemic Stroke (2017)
- AHA/ASA: Management of Post-stroke Depression (2016)
- AHA/ASA: Prevention of Stroke in Patients with Silent Cerebrovascular Disease (2016)
- AHA: Implementation of Telehealth in Cardiovascular and Stroke Care (2016)
- AHA/ASA: Telemedicine Quality and Outcomes in Stroke-A Scientific Statement (2016)
- AHA/ASA: Palliative and End-of-Life Care in Stroke (2016)
- AHA/ASA: Palliative Care in Cardiovascular Disease and Stroke-Scientific Statement (2016)
- AHA/ASA: Adult Stroke Rehabilitation and Recovery (2016)
- AHA/ASA: Guidelines for the Management of Patients with Unruptured Intracranial Aneurysms (2015)
- AHA/ASA: Guidelines for the Management of Spontaneous Intracerebral Haemorrhage (2015)
- AHA/ASA: Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment (2015)
- AHA/ASA: Management of Cerebral and Cerebellar Infarction with Swelling (2014)
- AHA/ASA: Guidelines for the Primary Prevention of Stroke (2014)
- AHA/ASA: Physical Activity and Exercise Recommendations for Stroke Survivors (2014)
- AHA/ASA: Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack (2014)
- AAN: Guidelines for the Prevention of Stroke in Women(2014)
- AAN: Periprocedural Management of Antithrombotic Medications in Patients with Ischemic Cerebrovascular Disease (2013)
- AHA/ASA: Guidelines for the Early Management of Adults with Ischemic Stroke (2007)
- AHA/ASA: Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack (2006)